| Dr Robert W Larkin, MD | |
|
694 Good Dr, Suite 200, Lancaster, PA 17601-2433 | |
| (717) 544-3514 | |
| (717) 544-3515 |
| Full Name | Dr Robert W Larkin |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology - Maternal & Fetal Medicine |
| Location | 694 Good Dr, Lancaster, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1669405361 | NPI | - | NPPES |
| 001584530 | Medicaid | PA | |
| 0113328 | Medicaid | NJ |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert W Larkin, MD 694 Good Dr, Suite 200, Lancaster, PA 17601-2433 Ph: (717) 544-3514 | Dr Robert W Larkin, MD 694 Good Dr, Suite 200, Lancaster, PA 17601-2433 Ph: (717) 544-3514 |
News Archive
Researchers estimate that up to $101 billion in health care spending is wasted each year due to over-treatment or the delivery of "low-value care." Low-value care includes a wide array of tests and treatments that are medically unnecessary and for which the potential for harm outweigh the potential for benefit. While researchers have charted the ongoing use of low-value care on national and regional levels, little research exists on how health systems across the country use low-value care and how they compare to each other.
VIVUS, Inc. announced today that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding its New Drug Application (NDA) for the investigational new drug QNEXA® (phentermine/topiramate) Controlled-Release Capsules. The FDA issued the CRL to communicate its decision that the NDA cannot be approved in its present form.
New York University has received a $2 million grant from the Mellon Foundation to expand its humanities faculty whose scholarship and teaching will focus on the past, present, and future of cities.
A recent study led by Gergely Lukacs, a professor at McGill University's Faculty of Medicine, Department of Physiology, and published in the January issue of Cell, has shown that restoring normal function to the mutant gene product responsible for cystic fibrosis (CF) requires correcting two distinct structural defects. This finding could point to more effective therapeutic strategies for CF in the future.
Scientists are a step closer to understanding what controls fine particulate matter in the Earth's atmosphere after identifying new linkages between natural contaminants and with manmade pollutants.
› Verified 9 days ago
Dr. Jon Michael Katz, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 694 Good Dr Ste 200, Lancaster, PA 17601 Phone: 717-544-3514 Fax: 717-544-3515 | |
George J Olt, MD Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 2102 Harrisburg Pike, Suite 102, Lancaster, PA 17601 Phone: 717-544-0340 | |
Dr. John Joseph Eichenlaub, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2128 Embassy Dr, Lancaster, PA 17603 Phone: 717-509-5090 Fax: 717-509-5078 | |
Pamela Martin Hershner, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 694 Good Dr, Lancaster, PA 17601 Phone: 717-544-3737 | |
Dr. Ani Elise Stull, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 694 Good Drive, Lancaster, PA 17601 Phone: 717-397-8177 | |
Katherine Hicks-courant, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 2102 Harrisburg Pike, Lancaster, PA 17601 Phone: 717-544-3968 Fax: 717-544-9401 | |
Dr. Bryon N Jacoby, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 694 Good Dr Ste 200, Lancaster, PA 17601 Phone: 717-544-3514 Fax: 717-544-3515 |